Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

International Journal of Cancer

Volumn 136, Issue 1, 2015, Pages 98-107

  Alemany, Laia ^a,b   Saunier, Maëlle ^a   Alvarado Cabrero, Isabel ^c   Quirõs, Beatriz ^a   Salmeron, Jorge ^c   Shin, Hai Rim ^d   Pirog, Edyta C ^e   Guimerà, Núria ^f   Hernandez Suarez, Gustavo ^g   Felix, Ana ^h   Clavero, Omar ^a   Lloveras, Belen ⁱ   Kasamatsu, Elena ^j   Goodman, Marc T ^k   Hernandez, Brenda Y ^k,l   Laco, Jan ^m   Tinoco, Leopoldo ⁿ   Geraets, Daan T ^f   Lynch, Charles F ^o   Mandys, Vaclav ^p   Poljak, Mario ^q   Jach, Robert ^r   Verge, Josep ^s   Clavel, Christine ^t   Ndiaye, Cathy ^u   Klaustermeier, Joellen ^a,b   Cubilla, Antonio ^j   Castellsagué, Xavier ^a   Bravo, Ignacio G ^a   Pawlita, Michael ^v   Quint, William G ^f   Muñoz, Nubia ^g   Bosch, Francesc X ^a   De Sanjosé, Silvia ^a,b   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

^d National Cancer Center   (South Korea)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f DDL DIAGNOSTIC LABORATORY   (Netherlands)

^g Instituto Nacional de Cancerología   (Colombia)

^h UNIVERSIDADE NOVA DE LISBOA   (Portugal)

ⁱ HOSPITAL DEL MAR   (Spain)

^j Instituto de Investigaciones en Ciencias de la Salud Universidad Nacional de Asuncion   (Paraguay)

^k UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

^m UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

ⁿ Hospital Oncologico SOLCA   (Ecuador)

^o UNIVERSITY OF IOWA   (United States)

^p CHARLES UNIVERSITY   (Czech Republic)

^q UNIVERSITY OF LJUBLJANA   (Slovenia)

^r JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^s Hospital Residencia Sant Camil   (Spain)

^t HÔPITAL MAISON BLANCHE   (France)

^u UNIVERSITÉ DE MONTRÉAL   (Canada)

^v GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

anal cancer; human papillomavirus; vaccine

Indexed keywords

VIRUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGE; AGED; ALPHAPAPILLOMAVIRUS; ANUS CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CROSS-SECTIONAL STUDY; DNA DETERMINATION; FEMALE; GENE EXPRESSION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 30; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 97; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NORTH AMERICA; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TIME SERIES ANALYSIS; TUMOR INVASION; TUMOR SUPPRESSOR GENE; WARTY BASALOID SUBTYPE OF SQUAMOUS CELL CARCINOMA; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; GENETICS; METABOLISM; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POISSON DISTRIBUTION; VIROLOGY;

AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POISSON DISTRIBUTION; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84928750547     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28963     Document Type: Article

References (36)

1. de Martel C, Ferlay J, Franceschi S, et al., Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
2. Forman D, Bray F, Brewster DH, et al., eds. Cancer Incidence in Five Continents, vol. X (electronic version). Lyon, IARC. 2013. Available from: http://ci5.iarc.fr; last accessed on November 16, 2013 ].
3. Grulich AE, Poynten IM, Machalek DA, et al., The epidemiology of anal cancer. Sex Health 2012; 9: 504-8.
4. Nielsen A, Munk C, Kjaer SK,. Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer 2012; 130: 1168-73.
5. van der Zee RP, Richel O, de Vries HJ, et al., The increasing incidence of anal cancer: can it be explained by trends in risk groups? Neth J Med 2013; 71: 401-11.
6. Palefsky J,. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009; 4: 52-6.
7. Diamond C, Taylor TH, Aboumrad T, et al., Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005; 32: 314-20.
8. Silverberg MJ, Lau B, Justice AC, et al,;. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54: 1026-34.
9. Hou JY, Smotkin D, Grossberg R, et al., High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer. J Acquir Immune Defic Syndr 2012; 60: 169-72.
10. A review of human carcinogens. Part B: Biological agents/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2009. Lyon, France.
11. Frisch M, Glimelius B, van den Brule AJ, et al., Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.
12. De Vuyst H, Clifford GM, Nascimento MC, et al., Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124: 1626-36.
13. Schiller JT, Castellsagué X, Garland SM,. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 2012; 30: F123-38.
14. de Sanjose S, Quint WG, Alemany L, et al.,; Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010; 11: 1048-56.
15. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press, 2000.
16. Kleter B, van Doorn LJ, ter Schegget J, et al., Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153: 1731-9.
17. Kleter B, van Doorn LJ, Schrauwen L, et al., Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-17.
18. Geraets D, Alemany L, Guimera N, et al,.; on behalf of the RIS HPV TT study group. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. J Pathol 2012. doi: 10.1002/path.4065.
19. Klaes R, Friedrich T, Spitkovsky D, et al., Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-84.
20. Halec G, Holzinger D, Schmitt M, et al., Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer 2013; 109: 172-83.
21. Barros AJ, Hirakata VN,. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3: 21.
22. Li N, Franceschi S, Howell-Jones R, et al., Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-35.
23. Halec G, Alemany L, Lloveras B, et al., Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer, submitted.
24. Steinau M, Unger ER, Hernandez BY, et al., Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis 2013; 17: 397-403.
25. Abramowitz L, Jacquard AC, Jaroud F, et al., Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011; 129: 433-9.
26. de Sanjosé S, Alemany L, Ordi J, et al.,; HPV VVAP study group. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 2013; 49: 3450-61.
27. Scholefield JH, Kerr IB, Shepherd NA, et al., Human papillomavirus type 16 DNA in anal cancers from six different countries. Gut 1991; 32: 674-6.
28. Guimerà N, Lloveras B, Lindeman J, et al.,; RIS HPV TT/HPV VVAPO study groups. The occasional role of low-risk human papillomaviruses 6, 11, 42, 44, and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology: results from a global study. Am J Surg Pathol 2013; 37: 1299-310.
29. Cornall AM, Roberts JM, Garland SM, et al., Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11. Int J Cancer 2013; 133: 2253-8.
30. Guan P, Howell-Jones R, Li N, et al., Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012; 131: 2349-59.
31. Koshiol J, Lindsay L, Pimenta JM, et al., Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 123-37.
32. Richel O, Quint KD, Lindenman J, et al., One lesion, one virus: Individual components of high-grade anal intraepithelial neoplasia in HIV-positive men contain a single HPV type. J Infect Dis, 2014.
33. Herfs M, Yamamoto Y, Laury A, et al., A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci USA 2012; 109: 10516-21.
34. Daling JR, Madeleine MM, Johnson LG, et al., Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270-80.
35. Valmary-Degano S, Jacquin E, Prétet JL, et al., Signature patterns of human papillomavirus type 16 in invasive anal carcinoma. Hum Pathol 2013; 44: 992-1002.
36. Halec G, Schmitt M, Dondog B, et al., Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 2013; 132: 63-71.